Publication: How Long Should Adjuvant Chemotherapy Be Given in Early Stage Colon Cancer?
Loading...
Open/View Files
Date
2013
Authors
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
OMICS Publishing Group
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Retsky, Michael. 2013. “How Long Should Adjuvant Chemotherapy Be Given in Early Stage Colon Cancer?” Journal of Clinical & Experimental Pathology 03 (01). doi:10.4172/2161-0681.1000136. http://dx.doi.org/10.4172/2161-0681.1000136.
Abstract
After diagnosis of colon cancer, the tumor is removed and the stage of the disease is provided by a pathologist. If the stage indicates relatively high risk of relapse, adjuvant chemotherapy is used for 6 or so months to reduce the probability of such relapse. This is a very common situation in oncology – used for many early stage colon cancer patients of whom there will be 143,000 in 2013 in US. This therapy is only partially effective since 52,000 patients will die of metastatic colon cancer in 2013. Despite being used for decades, there is much room for improvement.
Description
Other Available Sources
Research Data
Keywords
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service